{"nct_id":"NCT05429268","title":"Study to Evaluate the Safety and Efficacy of Tafasitamab Plus Lenalidomide in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (firmMIND)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2022-12-23","start_date_type":"ACTUAL","primary_completion_date":"2026-04-01","primary_completion_date_type":"ESTIMATED","completion_date":"2027-04-01","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["INCY"]}